Eirini Kanata

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Amyotrophic Lateral Sclerosis

Hydrogen Peroxide

Wastewater Treatment

Top Venues

Pathogens (Basel, Switzerland)

Molecules (Basel, Switzerland)

Molecular medicine (Cambridge, Mass.)

This page only lists publications with an associated author ORCID identifier.

Publications

Korina Karagianni, Dimitra Dafou, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Eirini Kanata
RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Ioannis Paspaltsis, Eirini Kanata, Sotirios Sotiriadis, Susana Silva Correia, Matthias Schmitz, Inga Zerr, Theodoros Sklaviadis, Konstantinos Xanthopoulos, Theodoros Sklaviadis
A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis. Pathogens (Basel, Switzerland) 13 (5) (2024)
Korina Karagianni, Dimitra Dafou, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Eirini Kanata
RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis. Molecular medicine (Cambridge, Mass.) 30 (1) (2024)
Athanasia Chatziefstathiou, Sezgi Canaslan, Eirini Kanata, Kostas Vekrellis, Vasilios C Constantinides, Georgios P Paraskevas, Elisabeth Kapaki, Matthias Schmitz, Inga Zerr, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Theodoros Sklaviadis
SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal Dementia. Biomedicines 12 (6) (2024)
Athanasia Chatziefstathiou, Sezgi Canaslan, Eirini Kanata, Kostas Vekrellis, Vasilios C Constantinides, Georgios P Paraskevas, Elisabeth Kapaki, Matthias Schmitz, Inga Zerr, Konstantinos Xanthopoulos, Theodoros Sklaviadis, Theodoros Sklaviadis
SIMOA Diagnostics on Alzheimer's Disease and Frontotemporal Dementia. Biomedicines 12 (6) (2024)
Ioannis Paspaltsis, Eirini Kanata, Sotirios Sotiriadis, Susana Silva Correia, Matthias Schmitz, Inga Zerr, Theodoros Sklaviadis, Konstantinos Xanthopoulos, Theodoros Sklaviadis
A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis. Pathogens (Basel, Switzerland) 13 (5) (2024)
Ioannis Paspaltsis, Eirini Kanata, Sotirios Sotiriadis, Susana Silva Correia, Matthias Schmitz, Inga Zerr, Theodoros Sklaviadis, Konstantinos Xanthopoulos, Theodoros Sklaviadis
A Comparison of RML Prion Inactivation Efficiency by Heterogeneous and Homogeneous Photocatalysis. Pathogens (Basel, Switzerland) 13 (5) (2024)
Eirini Kanata, Ioannis Paspaltsis, Sotiris Sotiriadis, Chrysanthi Berberidou, Sophia Tsoumachidou, Theodoros Sklaviadis, Konstantinos Xanthopoulos, Minas Arsenakis, Athanasios Arsenakis, Ioannis Poulios, Theodoros Sklaviadis
Photo-Fenton and TiO 2 Photocatalytic Inactivation of Model Microorganisms under UV-A; Comparative Efficacy and Optimization. Molecules (Basel, Switzerland) 28 (3) (2023)
Eirini Kanata, Ioannis Paspaltsis, Sotiris Sotiriadis, Chrysanthi Berberidou, Sophia Tsoumachidou, Theodoros Sklaviadis, Konstantinos Xanthopoulos, Minas Arsenakis, Athanasios Arsenakis, Ioannis Poulios, Theodoros Sklaviadis
Photo-Fenton and TiO 2 Photocatalytic Inactivation of Model Microorganisms under UV-A; Comparative Efficacy and Optimization. Molecules (Basel, Switzerland) 28 (3) (2023)
Eirini Kanata, Ioannis Paspaltsis, Sotiris Sotiriadis, Chrysanthi Berberidou, Sophia Tsoumachidou, Theodoros Sklaviadis, Konstantinos Xanthopoulos, Minas Arsenakis, Athanasios Arsenakis, Ioannis Poulios, Theodoros Sklaviadis
Photo-Fenton and TiO 2 Photocatalytic Inactivation of Model Microorganisms under UV-A; Comparative Efficacy and Optimization. Molecules (Basel, Switzerland) 28 (3) (2023)
Theodoros Sklaviadis, Eirini Kanata, Spyros Pettas, Nikolaos Bekas, Athanasios Dimitriadis, Garyfalia Kempapidou, Roza Lagoudaki, Paschalis Theotokis, Olga Touloumi, Nikoleta Delivanoglou, Evangelia Kesidou, Konstantinos Xanthopoulos, Nikolaos Grigoriadis, Fotini Nina Papavasiliou, Theodoros Sklaviadis
RNA Editing Alterations Define Disease Manifestations in the Progression of Experimental Autoimmune Encephalomyelitis (EAE). Cells 11 (22) (2022)
Eirini Kanata, Franc Llorens, Dimitra Dafou, Athanasios Dimitriadis, Katrin Thüne, Konstantinos Xanthopoulos, Nikolaos Bekas, Juan Carlos Espinosa, Matthias Schmitz, Alba Marín-Moreno, Vincenzo Capece, Orr Shormoni, Olivier Andréoletti, Stefan Bonn, Juan-Maria Torres, Isidro Ferrer, Inga Zerr, Theodoros Sklaviadis
RNA editing alterations define manifestation of prion diseases. Proceedings of the National Academy of Sciences of the United States of America 116 (39) (2019)